Merck Income After Taxes 2010-2024 | MKKGY

Merck annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Merck income after taxes for the quarter ending June 30, 2024 was $0.652B, a 15.37% decline year-over-year.
  • Merck income after taxes for the twelve months ending June 30, 2024 was $2.850B, a 11.69% decline year-over-year.
  • Merck annual income after taxes for 2023 was $3.067B, a 12.81% decline from 2022.
  • Merck annual income after taxes for 2022 was $3.518B, a 2.98% decline from 2021.
  • Merck annual income after taxes for 2021 was $3.626B, a 59.28% increase from 2020.
Merck Annual Income After Taxes
(Millions of US $)
2023 $3,067
2022 $3,518
2021 $3,626
2020 $2,277
2019 $1,450
2018 $1,291
2017 $2,950
2016 $1,807
2015 $1,241
2014 $1,548
2013 $1,606
2012 $745
2011 $876
2010 $12,338
2009 $10,807
Merck Quarterly Income After Taxes
(Millions of US $)
2024-06-30 $652
2024-03-31 $759
2023-12-31 $634
2023-09-30 $805
2023-06-30 $770
2023-03-31 $858
2022-12-31 $667
2022-09-30 $933
2022-06-30 $926
2022-03-31 $992
2021-12-31 $923
2021-09-30 $901
2021-06-30 $900
2021-03-31 $902
2020-12-31 $510
2020-09-30 $943
2020-06-30 $318
2020-03-31 $505
2019-12-31 $374
2019-09-30 $377
2019-06-30 $473
2019-03-31 $226
2018-12-31 $204
2018-09-30 $376
2018-06-30 $291
2018-03-31 $420
2017-12-31 $1,165
2017-09-30 $763
2017-06-30 $465
2017-03-31 $557
2016-12-31 $285
2016-09-30 $513
2016-06-30 $355
2016-03-31 $654
2015-12-31 $130
2015-09-30 $407
2015-06-30 $382
2015-03-31 $322
2014-12-31 $349
2014-09-30 $331
2014-06-30 $420
2014-03-31 $449
2013-12-31 $384
2013-09-30 $454
2013-06-30 $413
2013-03-31 $355
2012-12-31 $3,646
2012-09-30 $236
2012-06-30 $-78
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $-121
2011-03-31 $3,505
2010-12-31 $6,575
2010-09-30 $277
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00